Supreme Court Weighs Class Rules In Baycol Case

Law360, New York (January 18, 2011, 6:57 PM EST) -- The U.S. Supreme Court questioned both sides on the issue of class certification during oral arguments Tuesday in a putative class action alleging Bayer Corp. failed to warn that its recalled cholesterol drug Baycol could have fatal side effects.

The case could have a significant impact on class actions, attorneys said, because the Supreme Court must decide whether a ruling denying class certification in one case could prevent another plaintiff from bringing a similar class action if unaware of the previous suit.

“I'm certainly encouraged,” said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.